29 Mar 2017 | 3:08 AM
 

Marksans Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524404 | NSE Symbol: MARKSANS
46.75
0.05
(0.11 %)
28 Mar 2017 | 04:01 PM
Change company
  • Open (Rs)
    46.80
  • Prev. close (Rs.)
    46.70
  • High (Rs.)
    48.00
  • Low (Rs.)
    46.55
  • 52W H (Rs.)
    58.30
  • 52W L (Rs.)
    36.96
  • Volume (Rs.)
    752481
  • MCap (Rs in Cr.)
    1,913.55
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
1.92
Operating Margin (%)
15.25
Gross Profit Margin (%)
12.10
Net Profit Margin (%)
8.78
Total Debt/Equity
0.20
Dividend payout Ratio (Net Profit)
22.87
Earning Retention Ratio
78.30

News

06 Feb 2017 - 15:57:00-Marksans Pharma has reported of decline of 37 per cent in its consolidated net profit after taxes (P...
18 Oct 2016 - 14:59:00-Marksans Pharma Ltd an Indian pharma firm having global footprint on Tuesday said it has received ap...
26 Sep 2016 - 12:42:00-Shares of Marksans Pharma rallied over 12 per cent on the Bombay Stock Exchange after the drug maker...
26 Sep 2016 - 11:04:00-Leading pharma major Marksans Pharma Limited has said that USFDA has granted approval for an Abbrev...

Announcements

20-Feb-2017
Marksans Pharma - Completion of Inspection of Plant
06-Feb-2017
Marksans Pharma - Announces Q3 results (Standalone & Consolidated) & Limited Review Report (Standalone & Consolidated) for th
06-Feb-2017
Marksans Pharma - Results Press Release for December 31 2016
06-Feb-2017
Marksans Pharma Ltd. - Press Release
25-Jan-2017
Marksans Pharma - Q3 results on Feb 06 2017

Religare Research

28 Mar 2017 | 09:38 AM
• Gold hit one-month high after Trump doubts knock dollar and equity • Oil slumped again on doubts o...
28 Mar 2017 | 07:00 AM
It’s normal to see such volatile swings during the consolidation phase and we expect this to continu...
27 Mar 2017 | 07:13 PM
Gold prices retraced gains late Friday but still notched up a second weekly rise as concerns over th...
27 Mar 2017 | 06:00 PM
Tech Stars, comprises our 2 top stock picks filtered on the basis of momentum from our coverage univ...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
6,68,725 6.05 25.10 0.79
6,68,725 6.05 34.47 0.79
6,68,725 6.05 36.10 0.79
6,68,725 6.05 26.41 0.79

Shareholding Pattern

       
Promotors48.25%
Mutual Funds/UTI0.00%
FI/Banks5.02%
Insurance5.02%
FII10.52%
Government0.00%
Others7.29%

Peer Group

Company Intraday Graph
 Neuland Laboratories Ltd.
1,488.00(17.85)
3578
 Kovai Medical Center and Hospital Ltd.
1,299.95(-0.74)
11816
 Merck Ltd.
1,062.00(1.68)
3302
 AstraZeneca Pharma India Ltd.
934.20(-0.78)
3274

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Marksans Pharma Ltd.-3.506.90-8.15
NIFTY(S&P CNX)221.201,065.95355.65
BSE SENSEX666.203,198.841,116.71
BSE 500325.251,672.47615.82

Corporate Details

Key Personal
Mark Saldanha
Chairman & Managing Director
Sandra Saldanha
Whole Time Director
Vinay Gopal Nayak
Whole Time Director
Key Address
Registered Office
11th Floor Grandeur Veera Desai Extension Road Oshiwara Andheri (West),Mumbai,Maharashtra

Tel:022-40012000, Fax:022-40012011

info@marksanspharma.com
http://www.marksanspharma.com
Registrar Office
Bigshare Services Pvt. Ltd.
Add. :E/2 Ansa Industrial Estate Saki Vihar Road Saki Naka Andheri (E)

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Marksans Pharma Ltd. that will help you decide whether to buy, sell or hold Marksans Pharma Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Marksans Pharma Ltd.